• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

Chemical Profile of 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene (CAS No. 116963-80-5)

1-Iodo-4-(trans-4-pentylcyclohexyl)benzene, identified by its CAS number 116963-80-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound belongs to the class of iodoaromatics, featuring a benzene ring substituted with an iodine atom at the 1-position and a trans-4-pentylcyclohexyl group at the 4-position. The unique structural arrangement of this molecule imparts distinct chemical properties, making it a valuable intermediate in synthetic chemistry and a potential candidate for various applications.

The synthesis of 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene typically involves a series of well-established organic reactions, including Friedel-Crafts alkylation followed by iodination. The presence of the trans-4-pentylcyclohexyl moiety introduces steric hindrance and conformational flexibility, which can influence its reactivity and interaction with biological targets. This feature has been exploited in recent research to develop novel ligands for enzyme inhibition and receptor binding studies.

In recent years, 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene has been explored as a building block in the development of small-molecule drugs. Its iodine substituent makes it a suitable precursor for cross-coupling reactions, such as Suzuki-Miyaura and Stille couplings, which are pivotal in constructing complex molecular architectures. These reactions have been utilized to generate derivatives with enhanced pharmacological properties, including improved solubility and bioavailability.

One of the most promising applications of 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene is in the field of medicinal chemistry, particularly in the design of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are often targeted in the treatment of cancers and inflammatory diseases. Researchers have demonstrated that the bulky trans-4-pentylcyclohexyl group can be strategically positioned to interact with specific pockets on kinase domains, leading to potent inhibition. Preliminary studies have shown that derivatives of this compound exhibit promising activity against several kinases, including EGFR and JAK2.

Furthermore, the structural features of 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene have been leveraged in materials science applications. The compound's ability to form stable complexes with metal ions has made it useful in catalytic systems. For instance, it has been employed as a ligand in transition metal-catalyzed reactions, where its steric environment facilitates selective transformations. This has opened up new avenues for developing efficient synthetic methodologies for complex organic molecules.

The pharmacokinetic profile of 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene and its derivatives has also been a subject of extensive investigation. Studies have revealed that the presence of the trans-4-pentylcyclohexyl group can modulate metabolic stability, influencing drug clearance rates. Understanding these interactions is crucial for optimizing drug candidates to ensure prolonged therapeutic efficacy while minimizing side effects.

In conclusion, 1-Iodo-4-(trans-4-pentylcyclohexyl)benzene (CAS No. 116963-80-5) is a versatile compound with significant potential in pharmaceutical and materials science research. Its unique structural features enable diverse applications, from serving as an intermediate in drug synthesis to acting as a ligand in catalytic systems. Ongoing research continues to uncover new possibilities for this compound, reinforcing its importance in advancing chemical innovation.

• 114834-79-6(1-(Trans-4-N-Butylcyclohexyl)-4-Iodobenzene)
• 824401-01-6(Benzene, 1,1'-(1,2-diethyl-1,2-dimethyl-1,2-ethanediyl)bis[4-iodo-)
• 860639-66-3(Benzene,1-iodo-4-(4-propylcyclohexyl)-)
• 948553-20-6(Benzene,1-iodo-4-(4-pentylcyclohexyl)-)
• 111158-11-3(1-Iodo-4-(trans-4-N-propylcyclohexyl)benzene)
• 85547-11-1(〔trans-4-(trans-4-propylcyclohexyl)cyclohexyl〕iodobenzene)
• 90095-72-0(Benzene, 1,1'-(1,2-cyclopropanediyl)bis[4-iodo-, trans- (9CI))
• 918826-32-1(1-(Trans-4-Ethylcyclohexyl)-4-iodobenzene)
• 144970-30-9(TIPA)
• 912852-58-5(Benzene,1-iodo-4-(4'-pentyl[1,1'-bicyclohexyl]-4-yl)-)